Getagraph.com logo
NASDAQ Composite: ( -0.01%) 16 735
S&P 500
(0.80%) 5 277.51 points
Dow Jones
(1.51%) 38 686 points
Nasdaq
(-0.01%) 16 735 points
Oil
(-0.94%) $77.18
Gas
(0.35%) $2.58
Gold
(-0.79%) $2 347.70
Silver
(-3.10%) $30.56
Platinum
(0.63%) $1 044.50
USD/EUR
(-0.17%) $0.921
USD/NOK
(-0.49%) $10.49
USD/GBP
(-0.05%) $0.785
USD/RUB
(0.15%) $90.40

Realtime updates for NuGenerex [NUGX]

Exchange: OTC Sector: Healthcare Industry: Biotechnology
Last Updated17 May 2023 @ 09:42
25% discount on Stockinvest.us - Use code: Podcast

0.00% $ 0.000100

Live Chart Being Loaded With Signals

Commentary (17 May 2023 @ 09:42):

NuGenerex Immuno-Oncology, Inc., an oncology company, focuses on the modulation of the immune system to treat cancer. The company is developing immunotherapeutic products and vaccines...

Stats
Today's Volume 1.00
Average Volume 122.00
Market Cap 10 030.00
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -0.00167
ATR14 $0.0360 (36 000.00%)

Volume Correlation

Long: 0.00 (neutral)
Short: 0.00 (neutral)
Signal:(47.227) Neutral

NuGenerex Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

NuGenerex Correlation - Currency/Commodity

The country flag 0.22
( neutral )
The country flag 0.17
( neutral )
The country flag 0.00
( neutral )
The country flag -0.19
( neutral )
The country flag 0.02
( neutral )
The country flag 0.11
( neutral )

NuGenerex Financials

Annual 2020
Revenue: $0.00
Gross Profit: $0.00 (0.00 %)
EPS: $-0.0158
FY 2020
Revenue: $0.00
Gross Profit: $0.00 (0.00 %)
EPS: $-0.0158
FY 2019
Revenue: $0.00
Gross Profit: $0.00 (0.00 %)
EPS: $-0.0110

Financial Reports:

No articles found.

NuGenerex Options Data

Calls

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Puts

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

NuGenerex

NuGenerex Immuno-Oncology, Inc., an oncology company, focuses on the modulation of the immune system to treat cancer. The company is developing immunotherapeutic products and vaccines. It is developing AE37, a peptide immunotherapeutic vaccine, which is in Phase II clinical trials for the treatment of metastatic triple negative breast cancer. The company was formerly known as Antigen Express, Inc. The company was founded in 1993 and is based in Miramar, Florida. NuGenerex Immuno-Oncology, Inc.is a subsidiary of Generex Biotechnology Corporation.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators

Total Execution Time: 1.6266119480133 seconds
Number of API calls: 2
Number of DB calls: 8